In 2016, the global market for Electronic Data Capture Systems was worth USD 349.8 millions. Over the forecast period, the increasing complexity of managing clinical data generated during and after trials is expected to drive demand for EDC systems. According to the Center for Study of Drug Development, more than 80% of clinical trials fail because they do not meet regulatory requirements. This led to delayed drug commercialization. Manufacturers suffered a loss in revenue due to this. EDC systems can help to reduce this problem by simply capturing and managing clinical information.
U.S. EDC system market by component, 2014 – 2025 (USD million)
Companies are choosing to invest in eClinical solutions for managing clinical data. This is due to the many benefits it offers, including ease-of-use, integration of multiple functions and remote access to information. These factors will likely increase the adoption of EDC over the next few years.
The largest market share for EDC systems was held by services for it in 2016, due to the large number of Contract Research Organizations ("CROs") offering the clinical solutions. This is due to increasing regulatory scrutiny to comply with the complex requirements of clinical tests. It is expected to contribute to the rising demand in the future.
Due to increasing adoption by manufacturers to reduce data management costs, the software market is expected to see a lot of growth. EDC systems offer many benefits, including time savings and simplified regulatory processes. This will likely increase their adoption over the next few years.
Cloud-based delivery systems for EDC services will be in high demand, depending on their current implementation status and future growth prospects. This is due to the fact that cloud-based delivery systems for EDC services are increasingly recognized as being more efficient in many applications such as the trial design phase, data collection processes and monitoring & reporting generation.
The web-based portal has the largest market share due to the high maintenance costs associated with clinical trials. This high cost is believed to be a reason for pharmaceutical companies' high reluctance to invest in costly studies. Instead, they focus on more affordable options for information management such as web-based portals.
Phase III dominated the development phase segment in 2016, owing to its high demand for EDC software that can reduce costs and increase efficiency. Phase I, on the other hand is expected to grow at a high rate due to the importance of these systems in predicting future outcomes as well as eliminating drug candidates with low chances of success in clinical trials.
The demand for computer-assisted solutions has increased due to the large number of phase I trials, complex management and analysis of data acquired from various studies. Today's tools allow for the minimization of human errors, increased efficiency, and reduced costs by avoiding double data entry, manual transcribing, and manual sourcing. These components are expected to grow in popularity during the forecast period due to their direct data and remote information capture. Integration of EDC systems will result in lower prices for data management. This is expected to increase the market in developing countries.
CROs hold the largest market share. They are expected to show the fastest growth due to the increasing inclination of pharmaceutical firms toward reducing overall spending and involved benefits. This is anticipated to be the reason for the increased growth.
These benefits include increased cost-effectiveness, efficiency of services, improved compatibility, and a greater focus on core areas of development that are crucial to company growth. The use of a variety of software applications and support services to process clinical information is what it means.
Market share of global EDC systems by end-use in 2016, (%)
North America held the largest share of the market in 2016, due to its higher awareness and strict regulatory norms regarding the handling of clinical data. The presence of large pharmaceutical companies in the region will also increase the adoption of EDC systems during the forecast period.
The presence of many CROs that offer eClinical solutions for large pharmaceutical companies in Asia Pacific is expected to lead to a lucrative growth of the EDC system market.
Medidata Solutions, Inc., Oracle Corporation, BioClinica, Parexel International Corporation, Datatrak International, Inc., Medidata Solutions, Inc., eClinical Solutions, Merge Healthcare, Inc., OmniComm Systems, Inc., Acceliant, Clinipace, Inc., and Openclinica, LLC are some of the major players in this industry.
The market's most prominent players are Oracle Corporation and Medidata Solutions. Their product offerings account for a significant share of the market. Market leaders invest in extensive research to develop cost-effective, highly-technologically advanced products. This industry will benefit from the potential growth opportunities provided by efficient products.
Report Attribute |
More Details |
2020 market size |
USD 586.6 Million |
The revenue forecast for 2025 |
USD 1.16 Billion |
Growth Rate |
CAGR of 14.4% between 2017 and 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD Millions and CAGR between 2017-2025 |
Report coverage |
Forecast revenue, company ranking and competitive landscape, growth factors, trends |
Segments covered |
Component, delivery mode and development phase. End-use in the region. |
Regional scope |
North America; Europe, Asia Pacific; Latin America. Middle East & Africa |
Country coverage |
U.S.; Canada; UK; Germany; Japan; China; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
Medidata Solutions, Inc., Oracle Corporation, BioClinica, Parexel International Corporation, Datatrak International, Inc., Medidata Solutions, Inc., eClinical Solutions, Merge Healthcare, Inc., OmniComm Systems, Inc., Acceliant, Clinipace, Inc., Openclinica, LLC |
The scope of customization |
With purchase, you get free report customization (equivalent to up to 8 analysts working day) You can add or modify country, region and segment scope. |
Prices and purchase options |
You can get customized purchase options that meet your research needs. Explore your purchase options |
This report provides industry trends analysis and forecasts for revenue growth from 2014-2025. Grand View Research segmented this market by component, delivery mode and development phase.
Software
Services
Web-hosted
Licensee enterprise
Cloud-based
Phase I
Phase II
Phase III
Phase IV
Hospitals
CROs
Academic institutions
Pharma & Biotech Organizations
Manufacturers of Medical Devices
North America
The U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Saudi Arabia
b. Global market for electronic data capture systems was valued at USD 514.2 Million in 2019, and is forecast to grow to USD 586.6 Million in 2020.
What is the market growth rate for electronic data capture systems?b. Global electronic data capture system market is expected grow at a compound annual rate of 14.4% between 2019 and 2025, reaching USD 1,163.5 millions by 2025.
Which market segment had the largest share of electronic data capture systems?b. With a 52.31% share in 2019, North America was the dominant market for electronic data capture systems. This is due to the high awareness and strict regulatory norms regarding the handling of clinical data, as well as the presence of large pharmaceutical companies.
What are the major players in the electronic data capture system market?b. b.
What are the main factors that drive the market for electronic data capture systems?b. The market for electronic data capture systems is growing because of increasing complexity in managing clinical information before, during and after trials, increased cost-effectiveness, improved compatibility, and greater efficiency of services.
Up Market Research published a new report titled “Electronic Data Capture Systems Market research report which is segmented by Development Phase (III, II, IV, Phase I), by Delivery Mode (Licensed Enterprise, Web Based, Cloud Based), By Players/Companies Inc; OmniComm Systems, Inc; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc; Medidata Solutions, LLC, Inc; eClinicalSolutions; Merge Healthcare, Inc; Acceliant; Clinipace, Medidata Solutions, Inc; and Openclinica”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Electronic Data Capture Systems Market Research Report |
By Development Phase | III, II, IV, Phase I |
By Delivery Mode | Licensed Enterprise, Web Based, Cloud Based |
By Companies | Inc; OmniComm Systems, Inc; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc; Medidata Solutions, LLC, Inc; eClinicalSolutions; Merge Healthcare, Inc; Acceliant; Clinipace, Medidata Solutions, Inc; and Openclinica |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 249 |
Number of Tables & Figures | 175 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Development Phase (III, II, IV, Phase I), by Delivery Mode (Licensed Enterprise, Web Based, Cloud Based).
Electronic Data Capture Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Electronic Data Capture Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Electronic Data Capture Systems Market Report:
Some other reports from this category!